Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical stage pharmaceutical company. The Company is engaged in the research and development of light, radiation, sound and/or drug-activated small molecule compounds, their associated drug formulations and the light systems that activate them, with a primary objective of efficacy and a secondary objective of safety in the destruction of various... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > Theralase's Principal Investigators
View:
Post by Eoganacht on Mar 26, 2024 5:29pm

Theralase's Principal Investigators

Canada

Dr. Peter Black                   The Vancouver Prostate Cancer Centre: 604-875-5003
Dr. Ricardo Rendon Nova Scotia Health Authority (Halifax)
Dr. Jonathan Izawa London Health Sciences Centre
Dr. Girish Kulkarni University Health Network (Toronto)
Dr. Wassim Kassouf McGill University Health Centre (Montreal)

The Bladder Cancer Forum in Toronto is being co-chaired by Theralase's PI Dr. Girish Kulkarni. Both he and McGill PI Dr. Wassim Kassouf will be giving presentations unrelated to Theralase.

There will also be a virtual presentation by Dr. Michael Jewett from 1:30 - 2:00
Patient Engagement in Bladder Cancer


United States

Dr. Piyush Agarwal University of Chicago
Dr. Neal Shore Carolina Urological Research Centre
Dr. Gautam Jayra Urology Associates P.C.
Dr. Daniel Saltzstein Urology San Antonio
Dr. Kyle Richards University of Wisconsin Health University Hospital
 
There will be Theralase-unrelated presentations at the 2024 AUA Annual Meeting San Antonio by PI Dr. Neal Shore and PI Dr. Kyle Richards.

The 2 terminated clinical study sites are:Virginia UrologyMidlantic Urology
 
Comment by toade1313 on Mar 26, 2024 7:46pm
Sorry to see a 2nd site closed. 
Comment by toade1313 on Mar 26, 2024 8:46pm
Wonder what it means when Theralase's PI Dr Girish Kulkarni is giving a presentation unrelated to Theralase? Dr Michael Jewett's presentation is only virtual?